Furthermore, Herrera et al. [7] identified the endothelin-1 (ET-1)/vascular endothelial growth factor (VEGF) signalpeptide receptor as a promising therapeutic target for acute respiratory distress syndrome. This evidence concerns the gene EDN1 and acute respiratory distress syndrome.